Felix S Lichtenegger (Felix Lichtenegger)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Regulatory T Cells

Ejection Fraction

Dendritic Cells

Immune Response

Top Venues

Cancer immunology, immunotherapy : CII

Journal of clinical medicine

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Gerulf Hänel, Caroline Angerer, Katja Petry, Felix S Lichtenegger, Marion Subklewe
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens. Cancer immunology, immunotherapy : CII (2021)
Heleen H Van Acker, Maarten Versteven, Felix S Lichtenegger, Gils Roex, Diana Campillo-Davo, Eva Lion, Marion Subklewe, Viggo F I Van Tendeloo, Zwi N Berneman, Sébastien Anguille
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia. Journal of clinical medicine 8 (5) (2019)
Thomas Kohnke, Veronika K Wittmann, Veit L Bücklein, Felix S Lichtenegger, Zlatana Pasalic, Wolfgang Hiddemann, Karsten Spiekermann, Marion Subklewe
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200. British journal of haematology 179 (3) (2017)